Resources Contact Us Home
Ribonucleotide reductase inhibitors and methods of use

Image Number 16 for United States Patent #8372983.

Provided herein are novel compounds that inhibit ribonucleotide reductase (RR) by binding to RRM2 and interfering with the activity of the RRM1/RRM2 holoenzyme, as well as methods of synthesizing these novel compounds. The compounds may be used to inhibit RR activity and to treat various conditions associated with RRM2 expression, such as for example certain cancer types, mitochondrial diseases, or degenerative diseases.

  Recently Added Patents
Light source lighting device including a constant-current supply that is connected to a light source and supplies a constant current of a substantially constant magnitude to the light source,
Image processing apparatus and image processing method
High pressure refolding of protein aggregates and inclusion bodies
Scalable header extension
Method of optimizing air mover performance characteristics to minimize temperature variations in a computing system enclosure
Quantifying the risks of applications for mobile devices
Production of battery grade materials via an oxalate method
  Randomly Featured Patents
Circuit arrangement for processing sampled analogue electrical signals
Temporary package and method
Method of making a contact in a semiconductor device
Bone particle collection apparatus and method
Water amount controlling switch structure of water injection gun
Sensor for thermally ionizable particles and/or vapors
Optical wavelength locker module having a high thermal conductive material
Respiratory therapy system with electromechanical driver
Integrated catheter
Glass compression molding machine and machining chamber therefor